The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure
Launched by UNIVERSITY HOSPITAL BISPEBJERG AND FREDERIKSBERG · Dec 10, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Cardio-share Telemedicine Cross-sector Collaboration Model, is looking at how a new telemedicine approach can help manage patients with heart failure. Heart failure is a condition where the heart doesn't pump blood as well as it should, which can lead to hospital admissions. The study aims to understand what makes some patients more vulnerable to these health issues and to identify key elements that can help manage their care effectively using telemedicine tools. By comparing the number of hospital readmissions and patients' quality of life before and after implementing this model, researchers hope to find ways to improve care for those who frequently need hospital treatment.
To join the study, participants must have been admitted to the hospital for heart failure and either had a previous admission for the same issue in the last three months or at least two admissions in the past six months. Participants will receive support to use telemedicine tools, and their doctors will have access to video calls with heart specialists. Community health workers will also assist patients at home. This collaborative approach aims to provide better care and support for patients with heart failure, helping them manage their condition more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patients admitted with acute decompensated heart failure AND:
- • with previous admission with decompensated heart failure in the three-month period prior to the current admission or
- • who have two or more admissions in the 6 months prior to the current admission.
- Exclusion Criteria:
- • Patients who
- • have refused to share their data for health-quality projects
- • have already ongoing telemedicine management for heart failure
About University Hospital Bispebjerg And Frederiksberg
University Hospital Bispebjerg and Frederiksberg is a leading academic medical institution in Denmark, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge scientific inquiry with patient-centered care, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. The institution emphasizes a strong commitment to ethical standards and regulatory compliance, ensuring that all trials are designed to enhance medical knowledge and improve patient outcomes. With a focus on a wide range of therapeutic areas, University Hospital Bispebjerg and Frederiksberg strives to contribute significantly to the global medical community and the advancement of evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frederiksberg, , Denmark
Patients applied
Trial Officials
Kirsten Wisborg, MD,PhD,DrM
Study Director
University Hospital Bispebjerg and Frederiksberg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported